Biliary neoplasm – Basic Information

Go back

Biliary neoplasm refers to tumors that develop in the gallbladder or bile ducts, which are tubes that carry digestive fluid called bile from the liver to the small intestine. Most of these tumors are cancerous and can be challenging to treat because they are often discovered at later stages when symptoms appear.

Epidemiology

Biliary tract neoplasms are not common, but they are not extremely rare either. In the United States, approximately 6,000 to 7,000 new cases of gallbladder carcinoma (cancer of the gallbladder) are diagnosed each year, along with 3,000 to 4,000 new cases of bile duct carcinoma (cancer of the bile ducts, also called cholangiocarcinoma).[1] This means that roughly 8,000 to 10,000 people in the U.S. are diagnosed with biliary tract cancer annually.[5][6]

The number of people affected by biliary tract cancers is relatively small compared to other digestive system cancers. Gallbladder carcinoma is the fifth most common cancer of the gastrointestinal tract and is found incidentally in 1 to 3 percent of gallbladder removal surgeries (cholecystectomies) and in 0.5 to 7.4 percent of autopsies.[1] This suggests that some cases exist without causing noticeable symptoms during a person’s lifetime.

Age plays a significant role in the development of these cancers. Biliary neoplasms typically occur in older adults, with the highest number of cases found in people in their sixth and seventh decades of life (ages 50 to 70).[1][3] However, these cancers can develop at any age, although this is less common.

Gender differences are also observed in biliary tract cancers. Gallbladder carcinoma is three to five times more common in females than in males.[1] In contrast, bile duct cancer affects men and women more equally.[1]

Certain ethnic and geographic populations show higher rates of biliary tract cancers. Israelis, Japanese, Native Americans, Spanish Americans living in the southwestern United States, and Eskimos all have an increased risk of developing these cancers.[1] These variations suggest that both genetic factors and environmental or lifestyle factors may contribute to the disease.

Causes

The exact reasons why biliary neoplasms develop are not fully understood. However, research suggests there may be a step-by-step process similar to what happens in stomach and colon cancers. In the bile ducts and gallbladder, normal cells may undergo changes over time, transforming from normal tissue to metaplasia (abnormal cell changes), then to dysplasia (pre-cancerous cell changes), and finally to cancer.[1]

Unlike some other cancers, biliary neoplasms are not caused by infectious agents that spread from person to person. These cancers develop within the body due to a combination of genetic changes and long-term damage to the bile ducts or gallbladder. The bile ducts are part of the digestive system and are responsible for transporting bile, a fluid produced by the liver that helps digest fats. When the cells lining these structures become damaged over many years, they may eventually turn cancerous.

Some benign (non-cancerous) tumors and conditions can affect the biliary tract as well. Most are true growths, while a few result from abnormal development or inflammation. Although benign tumors usually do not cause serious health problems, some have the potential to transform into cancer over time, which is an important concern for doctors and patients.[9]

Risk Factors

Several factors have been identified that increase a person’s chance of developing biliary neoplasms. One of the most significant risk factors is the presence of gallstones, which are hardened deposits of digestive fluid that form inside the gallbladder. Gallstones are present in more than two-thirds of patients with gallbladder cancer.[6][1] Larger gallstones appear to carry a higher risk.

Chronic inflammation of the gallbladder, known as chronic cholecystitis, is another major risk factor. This long-term inflammation damages the gallbladder lining and can lead to cancerous changes over time.[1] Similarly, conditions that cause long-term inflammation of the bile ducts increase the risk of bile duct cancer.[8]

A condition called porcelain gallbladder, where calcium deposits build up in the gallbladder wall, also raises cancer risk. It is estimated that about 22 percent of patients with porcelain gallbladder will eventually develop gallbladder carcinoma.[1]

Choledochal cysts (abnormal dilations or pouches in the bile ducts present from birth) and abnormal connections between the pancreatic and bile ducts (anomalous pancreatico-biliary duct junctions) are additional risk factors.[1] These structural abnormalities can lead to bile flow problems and chronic irritation.

Polyps in the gallbladder that are larger than one centimeter in size are also associated with an increased cancer risk.[1] Not all polyps become cancerous, but larger ones are more worrisome and may need to be monitored or removed.

Other bile duct conditions such as primary sclerosing cholangitis (a disease where bile ducts become inflamed and scarred), liver cirrhosis, and Caroli’s disease (a rare congenital disorder affecting bile ducts) can also contribute to cancer development.[3][5]

Metabolic syndrome, which is a cluster of conditions including obesity, diabetes, high blood pressure, and elevated blood fats, has been linked to an increased risk of biliary cancers.[24] These conditions may create an environment in the body that encourages abnormal cell growth.

⚠️ Important
Having one or more risk factors does not mean a person will definitely develop biliary cancer. Many people with gallstones or chronic inflammation never develop cancer. However, being aware of these risk factors can help doctors identify individuals who may benefit from closer monitoring or preventive measures.

Symptoms

One of the major challenges with biliary neoplasms is that early diagnosis is difficult. Most patients do not experience symptoms until the cancer has grown or spread, making the disease harder to treat. When symptoms do appear, they are often vague and can easily be mistaken for other, less serious digestive problems.[1]

The most common symptom of bile duct and gallbladder cancers is jaundice, which causes a yellowing of the skin and the whites of the eyes. This happens when the tumor blocks the bile duct, preventing bile from flowing normally into the small intestine. As bile builds up in the body, it causes the yellow discoloration.[2][3]

Along with jaundice, patients may notice that their urine becomes dark in color, similar to tea or cola. At the same time, stools may become pale or clay-colored because bile is not reaching the intestines to give stool its normal brown color.[2][3]

Many people with biliary neoplasms experience pain in the upper right part of the abdomen, where the liver and gallbladder are located. This pain can be constant or come and go, and may feel like a dull ache or sharp discomfort.[1][2]

Unexplained weight loss is another common symptom. Patients may lose weight without trying, often because they have lost their appetite or because the cancer is affecting the body’s ability to absorb nutrients.[1][2] Loss of appetite itself can be a symptom, with patients simply not feeling hungry or interested in eating.

Nausea and vomiting are also frequently reported. These digestive symptoms can occur because the bile duct or digestive system is blocked or not functioning properly.[1][2]

Some patients develop a fever, which may be a sign of infection in the bile ducts or gallbladder. Itchy skin (also called pruritus) is another symptom that occurs with jaundice. The buildup of bile in the bloodstream can cause intense itching all over the body.[2][3]

General feelings of being unwell, such as malaise and fatigue, are common. Patients often describe feeling tired and weak, which can affect their daily activities and quality of life.[1]

Because these symptoms are similar to those of other conditions like gallstones or chronic cholecystitis, biliary cancer is often confused with these more common problems. This can delay diagnosis and treatment. At the time most patients are diagnosed, the cancer has already spread to nearby organs, lymph nodes, or distant parts of the body, making it much harder to treat successfully.[1]

Prevention

Because the exact causes of biliary neoplasms are not fully known, there are no guaranteed ways to prevent these cancers. However, understanding risk factors and taking steps to reduce them can potentially lower the chances of developing biliary tract cancers.

Since gallstones and chronic gallbladder inflammation are major risk factors for gallbladder cancer, addressing these conditions may help. People with symptoms of gallstones or chronic cholecystitis may benefit from medical treatment or surgery to remove the gallbladder. If gallstones are discovered, discussing treatment options with a doctor can prevent long-term complications.

Managing metabolic conditions such as obesity, diabetes, high blood pressure, and high cholesterol through healthy lifestyle choices may also reduce risk. Eating a balanced diet, exercising regularly, and maintaining a healthy weight are important steps. These habits can improve overall health and may reduce the risk of several types of cancer, including biliary tract cancers.[24]

People with known risk factors such as choledochal cysts, primary sclerosing cholangitis, or a family history of biliary cancers should have regular check-ups with their healthcare providers. Close monitoring can help detect any abnormal changes early, when treatment is most likely to be successful.

If gallbladder polyps larger than one centimeter are found during imaging tests, doctors may recommend removing the gallbladder to prevent cancer from developing. Regular screening with ultrasound or other imaging may be advised for people at higher risk.

There are currently no routine screening tests for biliary tract cancers in the general population. Screening is only recommended for people with specific risk factors or symptoms. Being aware of symptoms and seeking medical attention promptly if they occur is an important part of early detection.[2]

Pathophysiology

Understanding what happens in the body when biliary neoplasms develop helps explain why symptoms occur and how the disease progresses. The biliary system is a network of tubes and organs that work together to produce, store, and transport bile. Bile is a yellow-green fluid made by the liver that helps the body digest fats. It travels through small tubes inside the liver called intrahepatic bile ducts, then exits the liver through larger ducts called the right and left hepatic ducts. These join to form the common hepatic duct, which connects to the gallbladder through the cystic duct. The gallbladder stores and concentrates bile until it is needed. When a person eats, the gallbladder releases bile into the common bile duct, which carries it into the small intestine to aid digestion.[2][4]

Biliary neoplasms are classified based on where they develop in this system. Intrahepatic bile duct cancer forms in the small bile ducts inside the liver. This type makes up only about 10 percent of bile duct cancers.[15] Extrahepatic bile duct cancer develops outside the liver and is further divided into two types. Perihilar cholangiocarcinoma (also called a Klatskin tumor) occurs where the right and left hepatic ducts join just outside the liver. This is the most common location, accounting for about 50 percent of bile duct cancers. Distal cholangiocarcinoma develops further down the bile duct, closer to the small intestine, and makes up about 40 percent of cases.[2][5][15] Gallbladder cancer forms in the wall of the gallbladder and may grow into the liver.[5]

Most biliary tract cancers begin in the epithelial cells, which are the cells lining the inner walls of the gallbladder or bile ducts. The most common type is called adenocarcinoma, which makes up about 90 percent of all biliary tract cancers.[7] In adenocarcinoma, the cancer cells form gland-like structures. There are also rarer types, such as squamous cell carcinoma, sarcoma, and lymphoma.[7]

Many bile duct cancers are multifocal, meaning they arise in more than one location at the same time.[15] This makes treatment more complicated because the cancer is not confined to a single area.

When a tumor develops in the bile duct or gallbladder, it can block the flow of bile. This blockage causes bile to build up in the liver and bloodstream, leading to jaundice and other symptoms. The tumor can also grow into surrounding tissues and organs, such as the liver, pancreas, or small intestine. Cancer cells can spread to nearby lymph nodes or travel through the bloodstream to distant organs, a process called metastasis. Once the cancer has spread, it is considered advanced and much harder to cure.[1]

The five-year survival rate for gallbladder carcinoma is less than 5 percent, reflecting the aggressive nature of the disease and the fact that it is usually diagnosed at a late stage.[1] Most patients are considered unresectable (the cancer cannot be completely removed by surgery) at the time of diagnosis because the tumor has already spread to adjacent organs, lymph nodes, or distant sites.

Changes in the normal function of the biliary system affect digestion and overall health. Without proper bile flow, the body cannot digest fats efficiently, leading to nutritional problems. Blocked bile ducts can also cause infections and liver damage. These physical changes, combined with the cancer itself, significantly impact a patient’s quality of life and ability to tolerate treatment.

Ongoing Clinical Trials on Biliary neoplasm

  • Study of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Recruiting

    1 1
    Germany
  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1
    Poland Spain
  • Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

    Not recruiting

    1 1 1
    Belgium Denmark France Germany Italy Norway +2

References

https://pmc.ncbi.nlm.nih.gov/articles/PMC2727973/

https://www.cancer.gov/types/liver/bile-duct-cancer

https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/symptoms-causes/syc-20352408

https://willenbringlab.ucsf.edu/condition/bile-duct-cancer-cholangiocarcinoma

https://uthealthaustin.org/conditions/biliary-tract-cancer

https://www.dana-farber.org/cancer-care/types/biliary-cancer

https://cancer.ca/en/cancer-information/cancer-types/biliary-tract-gallbladder-and-bile-duct/what-are-biliary-tract-cancers

https://www.cancerresearchuk.org/about-cancer/bile-duct-cancer

https://pmc.ncbi.nlm.nih.gov/articles/PMC8299320/

https://www.cancer.gov/types/liver/bile-duct-cancer/treatment

https://www.cancer.org/cancer/types/bile-duct-cancer/treating/based-on-situation.html

https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/diagnosis-treatment/drc-20352413

https://www.nhs.uk/conditions/bile-duct-cancer/treatment/

https://www.mdanderson.org/cancer-types/bile-duct-cancer/bile-duct-cancer-treatment.html

https://www.ncbi.nlm.nih.gov/books/NBK65869/

https://www.cancerresearchuk.org/about-cancer/bile-duct-cancer/treatment

https://www.mskcc.org/cancer-care/types/bile-duct-cancer-cholangiocarcinoma/treatment

https://emedicine.medscape.com/article/2003836-overview

https://www.dana-farber.org/cancer-care/types/biliary-cancer/treatment

https://www.cancerresearchuk.org/about-cancer/bile-duct-cancer/living-with/advanced

https://pancare.org.au/cancer/biliary-cancer/biliary-cancer-diet-nutrition/?srsltid=AfmBOoo6HtIO20mW-50fXt3ew_123gFizFYBMLoJC42pM0FFNvYo8U0Z

https://www.cancerresearchuk.org/about-cancer/bile-duct-cancer/living-with/coping

https://cancer.ca/en/cancer-information/cancer-types/biliary-tract-gallbladder-and-bile-duct/supportive-care

https://cancercenter.gwu.edu/news/understanding-gallbladder-and-bile-duct-cancer-comprehensive-overview

https://health.clevelandclinic.org/living-with-cholangiocarcinoma-bile-duct-cancer

https://www.cancer.org/cancer/types/bile-duct-cancer/treating/based-on-situation.html

https://www.esmo.org/for-patients/patient-guides/biliary-tract-cancer-a-guide-for-patients

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What are biliary neoplasms?

Biliary neoplasms are tumors that develop in the gallbladder or bile ducts, which are tubes that carry digestive fluid called bile from the liver to the small intestine. Most biliary neoplasms are cancerous and include gallbladder cancer and bile duct cancer (cholangiocarcinoma).

Are biliary neoplasms common?

Biliary neoplasms are relatively rare but not extremely uncommon. In the United States, approximately 6,000 to 7,000 new cases of gallbladder cancer and 3,000 to 4,000 new cases of bile duct cancer are diagnosed each year.

What are the main symptoms of biliary tract cancers?

The main symptoms include yellowing of the skin and eyes (jaundice), dark urine, pale or clay-colored stools, pain in the upper right abdomen, unexplained weight loss, loss of appetite, nausea and vomiting, fever, and itchy skin. Unfortunately, symptoms often don’t appear until the cancer is at an advanced stage.

Who is most at risk for developing biliary neoplasms?

Risk is higher in people aged 50 to 70, women (for gallbladder cancer), those with gallstones or chronic gallbladder inflammation, people with certain congenital bile duct abnormalities, and individuals with metabolic conditions like obesity and diabetes. Certain ethnic groups, including Native Americans and Japanese, also have increased risk.

Can biliary tract cancers be prevented?

There are no guaranteed ways to prevent biliary neoplasms since the exact causes are not fully known. However, managing risk factors such as treating gallstones, maintaining a healthy weight, controlling diabetes and blood pressure, and having regular check-ups if you have risk factors may help reduce your chances. There are no routine screening tests for the general population.

🎯 Key takeaways

  • Biliary neoplasms include cancers of the gallbladder and bile ducts, with about 9,000 to 11,000 new cases diagnosed annually in the U.S.
  • These cancers are often discovered late because symptoms don’t appear until the disease has advanced, making early detection challenging.
  • Gallbladder cancer is three to five times more common in women, while bile duct cancer affects men and women more equally.
  • Gallstones are present in more than two-thirds of gallbladder cancer patients, making them a major risk factor.
  • Jaundice (yellowing of skin and eyes), dark urine, and pale stools are classic warning signs that should prompt immediate medical evaluation.
  • About 22 percent of people with porcelain gallbladder (calcium buildup in the gallbladder wall) will develop cancer.
  • Most biliary tract cancers are adenocarcinomas, which develop from the cells lining the inside of the bile ducts or gallbladder.
  • Managing metabolic conditions like obesity and diabetes, along with treating gallstones promptly, may help reduce risk of these cancers.